ProBioGen and Evotec Technologies Announce Successful Completion of Collaboration on Automated Cell Selection Technology

01-Sep-2006 - ProBioGen AG and Evotec Technologies GmbH have announced the successful completion of their collaboration - the joint evaluation of methods and instrumentation for the selection of high producer cells. ProBioGen could show based on it's cell-based assay technology, know how and expertise in cGMP ...

Fluidigm-Singapore completes final milestone toward full manufacturing operations

Off-shore fab positions Fluidigm to move rapidly into the real-time qPCR market

31-Aug-2006 - Fluidigm Corporation has announced that its Singapore-based manufacturing facility has ramped up to full process R&D and manufacturing operations, less than a year after opening its doors. The rapid startup boosts the Company's entry into the billion dollar real-time qPCR market, enabling ...

Europe challenges USA in stem cell research

31-Aug-2006 - A major research project linking the expertise of 20 leading organisations aims to keep Europe at the forefront of human embryonic stem cell research, thanks to a EUR12 million European grant. The ESTOOLS consortium, led by the Centre for Stem Cell Biology at the University of Sheffield in the ...

Buchwald wins Siegfried Medal from University of Zurich

30-Aug-2006 - The University of Zurich and Siegfried Ltd announced that Professor Stephen L. Buchwald of Massachusetts Institute of Technology will receive the 2006 Siegfried Medal for his achievements in process chemistry. Professor Buchwald's contributions have effected process chemistry primarily in the ...

Ciba Specialty Chemicals submits FDA master file for new antimicrobial test method NUMETRIKA

29-Aug-2006 - Ciba Specialty Chemicals together with its marketing partner BioGate has provided a comprehensive master file to the US Food and Drug Administration (FDA), for its new antimicrobial test method called NUMETRIKA, a scientific methodology for the evaluation of antimicrobial performance of surfaces ...

Geospiza Expands Collaboration with Applied Biosystems to Integrate Genetic Analysis Products

29-Aug-2006 - Geospiza announced the expansion of the companies' 2005 platform collaboration agreement and its participation in Applied Biosystems' Software Community Program. The first product resulting from the expanded collaboration integrates Applied Biosystems' GeneMapper® and SeqScape® genetic analysis ...

Agilent Technologies Partners with Proteome Systems for Glycomics Applications, Software Development

Collaboration to Hasten Drug & Diagnostic Marker Discovery

28-Aug-2006 - Proteome Systems Ltd. and Agilent Technologies Inc. announced the expansion of their cooperative marketing agreement to develop new workflow solutions for the discovery of diagnostic markers and drug targets by glycomics analysis. Proteome Systems will use its expertise in biomarker discovery ...

JPK Instruments acquires lpi light power instruments GmbH

28-Aug-2006 - JPK Instruments AG announced the 100% acquisition of lpi light power instruments GmbH (Berlin, Germany). lpi was founded in June 2005 and its focus is the development of optical nano-instrumentation for life science applications. The company holds pertinent intellectual properties and has built ...

Researchers Identify New Protein Biomarker Candidates That May Lead To Better Diagnosis And Treatment For Age-Related Diseases

Alzheimer's Disease, Parkinson's Disease and Dementia with Lewy Bodies Targeted in Protein Study Enabled by Applied Biosystems/MDS SCIEX's Advanced Technologies

25-Aug-2006 - Applied Biosystems, an Applera Corporation business, and its joint venture partner, MDS Sciex, a division of MDS Inc., announced the outcome of the scientific research community's most extensive, spinal fluid-based protein study on neurodegenerative diseases to date. Researchers from the ...

Celera Genomics Receives NIH Grant to Develop and Commercialize Avian Flu Diagnostic Test

24-Aug-2006 - Celera Genomics, an Applera Corporation business, announced that the National Institutes of Health (NIH) has awarded Celera approximately $900,000 to develop and commercialize an in vitro diagnostic (IVD) test for the highly pathogenic influenza A/H5 virus (Asian lineage, H5N1). The test Celera ...